Human T cell responses to autoantibody variable region peptides

Abstract

The origins and regulation of autoantibodies in SLE may involve idiotypic cell interactions. The purpose of this study was to determine if SLE patients have T cells reactive with the idiotopes of autoantibodies. Sequences of the variable regions of two DNA-binding autoantibodies (Vλ of antibody B3 and VH of 9G4) were selected according to the predicted location of their idiotypes defined previously by anti-idiotypic antibodies. The sequences were prepared as synthetic 16mer peptides (idiopeptides). Peripheral blood mononuclear cells were prepared from SLE patients (n = 28) and controls (n = 13) and put into multiple microcultures with idiopeptide for 6 days. The frequency of responding cultures was determined as those incorporating thymidine at levels above the mean plus three standard deviations of the control cultures lacking peptide. Of the 28 lupus patients, six responded to B3 idiopeptide and five to the 9G4 idiopeptide. Some patients responded to other idiopeptides, but only one normal individual responded to each reference peptide. The difference between the patient and control responses to all idiopeptides was significant by χ² analysis (P = 0.025). We conclude that patients with SLE show evidence of sensitisation of T cells to idiotopes of autoantibodies. Such anti-idiotypic T cells could either provide idiotype-specific help or suppression for autoantibody responses in SLE.

Keywords

anti-DNA antibodies T cells peptide idiotype

Get full access to this article

View all access options for this article.

References

Geha RS Presence of auto-anti-idiotypic antibody during the normal human immune response to tetanus toxoid antigen. J Immunol 1982; 129: 139-144.

Zouali M. , Eyquem A. Idiotypic anti-idiotypic interactions in SLE. Ann Immunol 1983; 1346: 377-397.

Zouali M. , Eyquem A. Idiotypic restriction in human autoantibodies to DNA in systemic lupus erythematosus . Immunol Lett 1984; 7: 187-193.

Wassermann NH et al. Anti-idiotypic route to anti-acetylcholine receptor antibodies and experimental myasthenia gravis. Proc Natl Acad Sci USA 1982; 79: 4810-4814.

Weiss S. , Bogen B. MHC class II restricted presentation of intracellular antigen. Proc Natl Acad Sci USA 1989; 86: 282-286.

King CA et al. Idiotypic IgM on a B-cell surface requires processing for recognition by anti-idiotypic T cells. Cell Immunol 1993 ; 147: 411-424.

Winfield JB , Faiferman I. , Kofler D. Avidity of anti-DNA antibodies in serum and IgG glomerular eluates from patients with systemic lupus erythematosus. J Clin Invest 1977; 59: 90-96.

Isenberg DA et al. Comparison of DNA idiotype in human sera: an international collaborative study of 19 idiotypes from 11 different laboratories. J Autoimmunity 1990; 3: 393-414.

Isenberg DA , Collins C. Detection of cross reactive anti-DNA antibody idiotypes on renal tissue bound immunoglobulins from lupus patients. J Clin Invest 1985; 76: 287-294.

10.

Hahn B. , Ebling FM Suppression of NZB/NZW murine nephritis by administration of a syngeneic monoclonal antibody to DNA. J Clin Invest 1983; 71: 1728-1736.

11.

Hahn B. , Ebling FM Suppression of murine lupus nephritis by administration of an anti-idiotypic antibody to anti-DNA. J Immunol 1984; 132: 187-190.

12.

Abdou NI et al. Anti-idiotypic antibodies against anti-DNA antibodies in sera of families of lupus patients. J Clin Immunol 1989; 9: 16-21.

13.

Mackworth-Young CG , Schwartz RS An idiotope-specific autoantibody in SLE. Clin Exp Immunol 1988; 71: 56-61.

14.

Ebling FM et al. A peptide derived from an autoantibody can stimulate T cells in the (NZB/NZW)F, mouse model of systemic lupus erythematosus. Arthritis Rheum 1993; 36: 355-364.

15.

O'Keefe TL et al. V region sequences of an idiotypically connected family of pathogenic anti-DNA autoantibodies. J Immunol 1990; 144: 4275-4283.

16.

Staines NA et al. Primary sequence and location of the idiotopes of V-88, a DNA-binding monoclonal autoantibody, determined by idiotope scanning with synthetic peptide on pins. Immunology 1993; 78: 371-378.

17.

Mendlovic S. et al. The genetic regulation of the induction of experimental SLE in mice. Immunology 1990 ; 69: 228-236.

18.

Isenberg DA et al. Independent analysis of the 16/6 idiotype model. J Immunol 1991; 147: 4172-4177.

19.

Ravirajan CT et al. Effect of histone and RNA-histone complexes on the disease process of murine SLE. Autoimmunity (in press).

20.

Mozes E. Experimental systemic lupus erythematosus; from pathogenic autoantibody to a peptide. Lupus 1995; 4 (suppl.2): 48.

21.

Ehrenstein MR et al. The serological and genetic characterization of a human monoclonal IgG anti-DNA idiotype. J Clin Invest 1994; 93: 1787-1797.

22.

Tan EM et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1983; 25: 1271-1277.

23.

Potter KN et al. Molecular characterization of a cross-reactive idiotope on human immunoglobulins utilizing the VH4-21 gene segment. J Exp Med 1993; 178: 1419-1428.

24.

Stevenson FK et al. Utilization of the VH4-21 gene segment by anti-DNA antibodies from patients with SLE. J Autoimmun 1993; 6: 809-825.

25.

Isenberg DA et al. Identification of the 9G4 idiotope in systemic lupus erythematosus . Br J Rheumatol 1993; 32: 876-882.

26.

Radic MZ et al. Residues that mediate DNA binding of autoimmune antibodies. J Immunol 1993; 150: 4966-4977.

27.

Krishman MR , Marion TN Structural similarity of antibody variable regions from immune and autoimmune anti-DNA antibodies. J Immunol 1993; 150: 4948-4957.

28.

Kalsi JK et al. Analysis of three new idiotypes on human monoclonal antibodies . Lupus (in press).

29.

Neimark J. , Briand JP Development of a fully automated multichannel peptide synthesizer with integrated TFA cleavage capability. Peptide Res 1993; 6: 219-228.

30.

Hay EM et al. The BILAG index: a reliable instrument for measuring clinical disease activity in SLE. Q J Med 1993; 86: 447-458.

31.

Worral J. et al. SLE: a rheumatological view. Q J Med 1990; 275: 319-330.

32.

Chicz RM et al. Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J Exp Med 1993; 178: 27-47.

33.

Kropshofer H. et al. Self-peptide released from class II HLA-DR 1 exhibits a hydrophobic two-residue contact motif. J Exp Med 1992; 175: 1799-1803.

34.

Chicz RM et al. Predominant naturally processed peptides bound to HLA-DR 1 are derived from MHC-related molecules and are heterogeneous in size. Nature 1992; 358: 764-768.

35.

Mendlovic S. et al. Anti-DNA idiotype- and anti-idiotype-specific T cell responses in patients with systemic lupus erythematosus and their first-degree relatives. Clin Exp Immunol 1990; 82: 504-508.

36.

Ward FJ et al. Mapping of public and private T cell idiotopes of DNA-binding autoantibodies associated with SLE. Lupus 1995; 4 (suppl.2): 104.